{"id":42984,"date":"2019-09-04T12:18:58","date_gmt":"2019-09-04T10:18:58","guid":{"rendered":"https:\/\/newserver.fyb.de\/wellington-partners-new-e210-million-life-science-fund\/"},"modified":"2019-09-04T12:18:58","modified_gmt":"2019-09-04T10:18:58","slug":"wellington-partners-new-e210-million-life-science-fund","status":"publish","type":"post","link":"https:\/\/www.fyb.de\/en\/wellington-partners-new-e210-million-life-science-fund\/","title":{"rendered":"Wellington Partners: new \u20ac210 million life science fund"},"content":{"rendered":"<p>Munich \u2014 Inter\u00adna\u00adtio\u00adnal law firm <strong>Clif\u00adford Chance<\/strong> has advi\u00adsed <strong>Welling\u00adton Part\u00adners<\/strong> on its successful fund\u00adrai\u00adsing for its fifth fund, Welling\u00adton Part\u00adners Life Science Fund V (WPLS\u2011V). The fund closed at <strong>\u20ac210 million<\/strong>, making it Welling\u00adton Part\u00adners\u2019 largest life science fund to&nbsp;date.<\/p>\n<p>Welling\u00adton Part\u00adners is a leading Euro\u00adpean venture capi\u00adtal firm inves\u00adt\u00ading in early and growth stage life science compa\u00adnies. The funds from WPLS V will be spent on a port\u00adfo\u00adlio of appro\u00adxi\u00adm\u00adately 15 to 20 compa\u00adnies that are active in biotech\u00adno\u00adlogy or are deve\u00adlo\u00adping new thera\u00adpies and medi\u00adcal devices. Selec\u00adted invest\u00adments in diagno\u00adstics and digi\u00adtal health are also part of the invest\u00adment stra\u00adtegy. The geogra\u00adphi\u00adcal focus is on Europe, in parti\u00adcu\u00adlar the German-spea\u00adking region. In addi\u00adtion, isola\u00adted invest\u00adments in North America or Asia are also being considered.<\/p>\n<p>WPLS\u2011V gained many new well-known inves\u00adtors such as KfW Capi\u00adtal, Talanx and the U.S. UTIMCO, the Univer\u00adsity of Texas\/Texas A&amp;M Invest\u00adment Company. Exis\u00adting inves\u00adtors such as the Euro\u00adpean Invest\u00adment Fund and the Euro\u00adpean Invest\u00adment Bank also participated.<\/p>\n<p>The advi\u00adsing Clif\u00adford Chance team was led by<strong> part\u00adner Sonya Pauls<\/strong><strong>(photo,<\/strong> Corporate\/Private Equity, Munich).<\/p>\n<p><strong>About Clif\u00adford Chance<\/strong><br>\nClif\u00adford Chance, one of the worl\u00add\u2019s leading law firms, is present for its clients with around 3,400 legal advi\u00adsors in all major busi\u00adness centers around the world. \u2014 In Germany, Clif\u00adford Chance is repre\u00adsen\u00adted by around 300 lawy\u00aders, audi\u00adtors, tax advi\u00adsors and soli\u00adci\u00adtors in D\u00fcssel\u00addorf, Frank\u00adfurt am Main and Munich.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Munich \u2014 Inter\u00adna\u00adtio\u00adnal law firm Clif\u00adford Chance has advi\u00adsed Welling\u00adton Part\u00adners on its successful fund\u00adrai\u00adsing for its fifth fund, Welling\u00adton Part\u00adners Life Science Fund V (WPLS\u2011V). The fund closed at \u20ac210 million, making it Welling\u00adton Part\u00adners\u2019 largest life science fund to&nbsp;date. Welling\u00adton Part\u00adners is a leading Euro\u00adpean venture capi\u00adtal firm inves\u00adt\u00ading in early and growth&nbsp;[\u2026]<\/p>\n","protected":false},"author":2,"featured_media":42993,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1366],"tags":[],"class_list":["post-42984","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-news-en","news-category-venture-capital-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Wellington Partners: new \u20ac210 million life science fund - FYB Financial Yearbook<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fyb.de\/en\/wellington-partners-new-e210-million-life-science-fund\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Wellington Partners: new \u20ac210 million life science fund - FYB Financial Yearbook\" \/>\n<meta property=\"og:description\" content=\"Munich \u2014 Inter\u00adna\u00adtio\u00adnal law firm Clif\u00adford Chance has advi\u00adsed Welling\u00adton Part\u00adners on its successful fund\u00adrai\u00adsing for its fifth fund, Welling\u00adton Part\u00adners Life Science Fund V (WPLS\u2011V). The fund closed at \u20ac210 million, making it Welling\u00adton Part\u00adners\u2019 largest life science fund to&nbsp;date. Welling\u00adton Part\u00adners is a leading Euro\u00adpean venture capi\u00adtal firm inves\u00adt\u00ading in early and growth [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fyb.de\/en\/wellington-partners-new-e210-million-life-science-fund\/\" \/>\n<meta property=\"og:site_name\" content=\"FYB Financial Yearbook\" \/>\n<meta property=\"article:published_time\" content=\"2019-09-04T10:18:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fyb.de\/wp-content\/uploads\/2019\/09\/a-sonyapauls.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"420\" \/>\n\t<meta property=\"og:image:height\" content=\"347\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Tatjana Anderer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tatjana Anderer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.fyb.de\/en\/wellington-partners-new-e210-million-life-science-fund\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/wellington-partners-new-e210-million-life-science-fund\/\"},\"author\":{\"name\":\"Tatjana Anderer\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\"},\"headline\":\"Wellington Partners: new \u20ac210 million life science fund\",\"datePublished\":\"2019-09-04T10:18:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/wellington-partners-new-e210-million-life-science-fund\/\"},\"wordCount\":242,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/wellington-partners-new-e210-million-life-science-fund\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2019\/09\/a-sonyapauls.jpg\",\"articleSection\":[\"General\",\"Featured\",\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.fyb.de\/en\/wellington-partners-new-e210-million-life-science-fund\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fyb.de\/en\/wellington-partners-new-e210-million-life-science-fund\/\",\"url\":\"https:\/\/www.fyb.de\/en\/wellington-partners-new-e210-million-life-science-fund\/\",\"name\":\"Wellington Partners: new \u20ac210 million life science fund - FYB Financial Yearbook\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/wellington-partners-new-e210-million-life-science-fund\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/wellington-partners-new-e210-million-life-science-fund\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2019\/09\/a-sonyapauls.jpg\",\"datePublished\":\"2019-09-04T10:18:58+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.fyb.de\/en\/wellington-partners-new-e210-million-life-science-fund\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fyb.de\/en\/wellington-partners-new-e210-million-life-science-fund\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/wellington-partners-new-e210-million-life-science-fund\/#primaryimage\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2019\/09\/a-sonyapauls.jpg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2019\/09\/a-sonyapauls.jpg\",\"width\":420,\"height\":347},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fyb.de\/en\/wellington-partners-new-e210-million-life-science-fund\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.fyb.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Wellington Partners: new \u20ac210 million life science fund\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fyb.de\/en\/#website\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"name\":\"FYB Financial Yearbook\",\"description\":\"For Your Business\",\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fyb.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\",\"name\":\"FYB Financial Yearbook\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"caption\":\"FYB Financial Yearbook\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\",\"name\":\"Tatjana Anderer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"caption\":\"Tatjana Anderer\"},\"description\":\"Gr\u00fcnderin des FYB-Verlag\",\"sameAs\":[\"http:\/\/neu.fyb.de\"],\"url\":\"https:\/\/www.fyb.de\/en\/author\/tanderer\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Wellington Partners: new \u20ac210 million life science fund - FYB Financial Yearbook","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fyb.de\/en\/wellington-partners-new-e210-million-life-science-fund\/","og_locale":"en_US","og_type":"article","og_title":"Wellington Partners: new \u20ac210 million life science fund - FYB Financial Yearbook","og_description":"Munich \u2014 Inter\u00adna\u00adtio\u00adnal law firm Clif\u00adford Chance has advi\u00adsed Welling\u00adton Part\u00adners on its successful fund\u00adrai\u00adsing for its fifth fund, Welling\u00adton Part\u00adners Life Science Fund V (WPLS\u2011V). The fund closed at \u20ac210 million, making it Welling\u00adton Part\u00adners\u2019 largest life science fund to&nbsp;date. Welling\u00adton Part\u00adners is a leading Euro\u00adpean venture capi\u00adtal firm inves\u00adt\u00ading in early and growth [&hellip;]","og_url":"https:\/\/www.fyb.de\/en\/wellington-partners-new-e210-million-life-science-fund\/","og_site_name":"FYB Financial Yearbook","article_published_time":"2019-09-04T10:18:58+00:00","og_image":[{"width":420,"height":347,"url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2019\/09\/a-sonyapauls.jpg","type":"image\/jpeg"}],"author":"Tatjana Anderer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Tatjana Anderer","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fyb.de\/en\/wellington-partners-new-e210-million-life-science-fund\/#article","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/wellington-partners-new-e210-million-life-science-fund\/"},"author":{"name":"Tatjana Anderer","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce"},"headline":"Wellington Partners: new \u20ac210 million life science fund","datePublished":"2019-09-04T10:18:58+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fyb.de\/en\/wellington-partners-new-e210-million-life-science-fund\/"},"wordCount":242,"commentCount":0,"publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"image":{"@id":"https:\/\/www.fyb.de\/en\/wellington-partners-new-e210-million-life-science-fund\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2019\/09\/a-sonyapauls.jpg","articleSection":["General","Featured","News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.fyb.de\/en\/wellington-partners-new-e210-million-life-science-fund\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.fyb.de\/en\/wellington-partners-new-e210-million-life-science-fund\/","url":"https:\/\/www.fyb.de\/en\/wellington-partners-new-e210-million-life-science-fund\/","name":"Wellington Partners: new \u20ac210 million life science fund - FYB Financial Yearbook","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fyb.de\/en\/wellington-partners-new-e210-million-life-science-fund\/#primaryimage"},"image":{"@id":"https:\/\/www.fyb.de\/en\/wellington-partners-new-e210-million-life-science-fund\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2019\/09\/a-sonyapauls.jpg","datePublished":"2019-09-04T10:18:58+00:00","breadcrumb":{"@id":"https:\/\/www.fyb.de\/en\/wellington-partners-new-e210-million-life-science-fund\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fyb.de\/en\/wellington-partners-new-e210-million-life-science-fund\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/wellington-partners-new-e210-million-life-science-fund\/#primaryimage","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2019\/09\/a-sonyapauls.jpg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2019\/09\/a-sonyapauls.jpg","width":420,"height":347},{"@type":"BreadcrumbList","@id":"https:\/\/www.fyb.de\/en\/wellington-partners-new-e210-million-life-science-fund\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fyb.de\/en\/"},{"@type":"ListItem","position":2,"name":"Wellington Partners: new \u20ac210 million life science fund"}]},{"@type":"WebSite","@id":"https:\/\/www.fyb.de\/en\/#website","url":"https:\/\/www.fyb.de\/en\/","name":"FYB Financial Yearbook","description":"For Your Business","publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fyb.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.fyb.de\/en\/#organization","name":"FYB Financial Yearbook","url":"https:\/\/www.fyb.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","caption":"FYB Financial Yearbook"},"image":{"@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce","name":"Tatjana Anderer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","caption":"Tatjana Anderer"},"description":"Gr\u00fcnderin des FYB-Verlag","sameAs":["http:\/\/neu.fyb.de"],"url":"https:\/\/www.fyb.de\/en\/author\/tanderer\/"}]}},"_links":{"self":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/42984","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/comments?post=42984"}],"version-history":[{"count":0,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/42984\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media\/42993"}],"wp:attachment":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media?parent=42984"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/categories?post=42984"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/tags?post=42984"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}